Nov 10, 2021 / 10:00PM GMT
Operator
Greetings. Welcome to the Navidea Q3 2021 Earnings Conference Call. (Operator Instructions) Please note, this conference is being recorded.
I will now turn the conference over to your host, Mike Rosol, CMO. You may begin.
Michael Stanley Rosol - Navidea Biopharmaceuticals, Inc. - Senior VP & Chief Medical Officer
Thank you all for joining us today. This call is being webcast live on our website, ir.navidea.com, and a replay will be made available. Following the prepared remarks, we will be conducting a question-and-answer segment, where we will read submitted questions and provide our responses. Navidea's Vice President of Finance and Administration, Erika Eves, will be joining me on the call today.
During the course of this conference call, we will be making forward-looking statements regarding future events and the future performance of the company. These events relate to our business plans to develop Navidea's molecular diagnostics and immunotherapeutics, which include clinical and regulatory developments and timing of clinical data
Q3 2021 Navidea Biopharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot